Study of Eylea for preterm babies with retinopathy of prematurity in the UK
Treatments studied
Part of Eyes & vision, Genetic & congenital clinical trials.
This study collects information on how the medicine Eylea is given to preterm babies with retinopathy of prematurity (an eye problem in premature infants) using a special dosing device. The goal is to see how the treatment works in everyday hospital care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born between the last quarter of 2023 and the end of 2026.
- Your baby received care in a participating UK neonatal unit.
- Your baby was diagnosed with retinopathy of prematurity (ROP) in at least one eye.
- We have your baby's gestational age (how many weeks they were at birth).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at newborn eye exams and genetic information to better understand why some premature infants develop a serious vision problem called ROP. You may be invited because your baby needs routine eye screening or is being moved for specialized eye care.
This study looks at eye structure in children who were in an earlier premature-baby eye study and are now around 4.5–5 years old. It may help researchers better understand how eye disease in prematurity develops and how to monitor it.
This study is a European registry that collects medical information (stored electronically) about babies who have retinopathy of prematurity (ROP) severe enough to need treatment. It may help doctors understand outcomes and improve care by tracking real-world results.
This trial tests whether giving propranolol by mouth to certain very premature babies with early eye changes can stop retinopathy of prematurity from getting worse. It may help reduce the need for eye treatments later on.
This study uses pictures to map the tiny blood vessels in an infant’s retina (the back of the eye). It may help researchers better understand how eye blood vessel growth happens in premature babies who need screening for ROP (retinopathy of prematurity).
This study looks at how often low oxygen levels happen in premature babies when they get eye injections for a serious eye condition. The goal is to understand the risks and make the procedure safer.
Hear when a new Retinopathy of Prematurity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.